4//SEC Filing
ENZO BIOCHEM INC 4
Accession 0000930413-08-000783
CIK 0000316253operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:38 PM ET
Size
5.7 KB
Accession
0000930413-08-000783
Insider Transaction Report
Form 4
GOLDBERG DAVID C
VP, Corporate Development
Transactions
- Exercise/Conversion
Restricted Stock
2008-02-04+2,000→ 94,391 total
Footnotes (2)
- [F1]On February 4, 2008, the Reporting Person was granted 2,000 shares of restricted common stock, par value $.01 (the "Restricted Stock") as compensation for serving as a officer of the Issuer. The Restricted Stock is subject to a three-year vesting period, subject to acceleration in certain circumstances.
- [F2]As of the date hereof, the Reporting Person directly beneficially owned 41,972 shares of Common Stock, 979 shares indirectly beneficially owned through the UGMA accounts of the Reporting Person's children, 3,102 shares of Common Stock in the Issuer's 401(K) Plan and 48,338 options to purchase Common Stock, par value $0.01 per share, which are currently exercisable. The Reporting Person also owns 2,000 shares of Restricted Stock that are not deemed to be beneficially owned because they are not exercisable within the next 60 days.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000316253
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:38 PM ET
- Size
- 5.7 KB